
MOTS-c
From £20
In stock, ships today
Tesamorelin 10mg + CJC-1295 No DAC 5mg + Ipamorelin 5mg
5.0 on REVIEWS.io, read 20 reviewsIn this bundle 3 items
Save £13 (14%) against buying each vial separately
Third-party lab reports
One for each compound. Every vial is sealed separately and nothing is mixed.
This research bundle combines two GHRH analogues, Tesamorelin and CJC-1295 (without DAC), with the selective ghrelin receptor agonist Ipamorelin, supplied as three separate vials. It supports direct comparison of two GHRH receptor agonists with different stability profiles, each studied alongside the same GHS-R1a agonist.
Tesamorelin and CJC-1295 No DAC both act at the growth hormone-releasing hormone receptor (GHRH-R) on somatotroph cells. Tesamorelin carries a trans-3-hexenoyl modification, while CJC-1295 No DAC (Modified GRF 1-29) uses four amino acid substitutions, and each resists enzymatic degradation in a different way. Ipamorelin acts at the growth hormone secretagogue receptor (GHS-R1a) and is noted in research for its selectivity, with minimal effect on cortisol and prolactin. Together they allow the two GHRH analogues to be compared directly, and each to be studied for synergy with ghrelin receptor signalling.
Shipped in plain, unbranded packaging from our United Kingdom warehouse. Damaged on arrival? Tell us within 48 hours and we’ll put it right. Shipping and returns
For laboratory research use only. Not for human or veterinary use.